Phase II Study on the Efficacy of KN046 Plus Nab-Paclitaxel: Promising Results for Advanced Triple-Negative Breast Cancer Patients
Cipla Breast Cancer Abraxane Nab-Paclitaxel Injection, 100mg Inj, 100 mg at Rs 100/piece in Mumbai
Types of Chemotherapy for Secondary Breast Cancer: Nab Paclitaxel - Make 2nds Count
JVD | Free Full-Text | Effect of Mirogabalin on Chemotherapy-Induced Peripheral Neuropathy Caused by Gemcitabine plus Nab-Paclitaxel Therapy in Pancreatic Cancer Patients: A Pilot Study
Impact of Nab–Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer | Anticancer Research
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 ...
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial - The Lancet Oncology
Nab-paclitaxel (Abraxane®) - Pancreatic Cancer UK
Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database | Scientific Reports
Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity | BMJ Open
Nab‑paclitaxel plus gemcitabine as first‑line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2
Cancer Care Asia - Nab-paclitaxel (Abraxane) Nab-paclitaxel is a chemotherapy drug and is also known by its brand name, Abraxane. It combines the chemotherapy drug paclitaxel with a protein called albumin. It
Nab-paclitaxel (Abraxane®) - Pancreatic Cancer UK
Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer | Journal of Pancreatology
Application of two lines of chemotherapy: gemcitabine with nab-paclitaxel and liposomal irinotecan with 5-fluorouracil and leucovorin in patient with advanced pancreatic adenocarcinoma | OncoReview
Bevacizumab treatment concurrent with nab-paclitaxel chemotherapy is... | Download Scientific Diagram
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 ...
A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact - ScienceDirect
SWOG S1505: results of chemotherapy (mFOLFIRINOX) versus perioperative Gemcitabine / nab-Paclitaxel for resectable pancreatic ductal adenocarcinoma (PDA) - Onco Americas
Cells | Free Full-Text | Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
a Progression-free survival with each chemotherapy. Solid line. Nab-PTX... | Download Scientific Diagram
The potential feasibility of nab-paclitaxel as the first-line chemotherapy for ovarian cancer: clinical development and future perspectives | Archives of Gynecology and Obstetrics
Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer | BMC Cancer | Full Text
Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis | springermedizin.de
